UCLA-Community Breast Cancer Collaborative Clinical Translational Research Program

摘要

The purpose of this proposal was to develop a consortium of community physicians committed to study novel approaches to the treatment and prevention of breast cancer, provide them with a clinical trials infrastructure linked to an academic center with expertise in basic research and the design and regulation of clinical investigation and to form partnerships with the pharmaceutical industry to facilitate the rapid translation of novel therapeutic approaches to breast cancer. At the time of our most recent annual progress report, we had succeeded in opening additional research sites aimed at increasing participation by patients from underserved populations, and initiating new, investigator-initiated clinical trials. Over the last year of support, the clinical trials network continued to expand and additional breast cancer clinical trials were initiated. Due to a variety of challenges being faced at most academic institutions, over the last two years accrual to clinical trials of patients with cancers other than breast cancer within the UCLA-CORN has decreased. Due to the enhanced support provided through this proposal, we were able to sustain our annual growth in accrual to breast cancer studies.